Taurine deficiency and MELAS are closely related syndromes

Advances in Experimental Medicine and Biology

Volumn 776, Issue , 2013, Pages 153-165

  Schaffer, Stephen W ^a   Jong, Chian Ju ^a   Warner, Danielle ^a   Ito, Takashi ^b   Azuma, Junichi ^b  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TAURINE;

AMINO ACID DEFICIENCY; AMINOACYLATION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; DIABETES MELLITUS; DISEASE ASSOCIATION; EYE DISEASE; GASTROINTESTINAL SYMPTOM; GROWTH DISORDER; HEARING IMPAIRMENT; HUMAN; KIDNEY DISEASE; MELAS SYNDROME; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SYMPTOM ASSESSMENT; TAURINE DEFICIENCY; ANIMAL; ANTIBODY SPECIFICITY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; REVIEW;

ANIMALS; GROWTH AND DEVELOPMENT; HUMANS; MELAS SYNDROME; ORGAN SPECIFICITY; TAURINE;

MLCS; MLOWN;

EID: 84878784151     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-6093-0_16     Document Type: Article

References (42)

1. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, Osame M, Tanaka H (1995) Cardiac involvement in mitochondrial diseases. Circulation 91:955-961.
2. Anderson PA, Baker DH, Corbin JE, Helper LC (1979) Biochemical lesions associated with taurine deficiency in the cat. J Anim Sci 49:1227-1234.
3. Arakawa K, Kudo T, Ikawa M, Morikawa N, Kawai Y, Sahashi K, Lee JD, Kuriyama M, Miyamori I, Okazawa H, Yoneda M (2010) Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to L-arginine infusion. Circ J 74:2702-2711.
4. Azuma J, Sawamura A, Awata N, Hasegawa H, Ogura K, Harada H, Ohta H, Yamauchi K, Kishimoto S (1983) Double-blind randomized crossover trial of taurine in congestive heart failure. Curr Therapeut Res 34:543-557.
5. Bagley PJ, Stipanuk MH (1995) Rats fed a low protein diet supplemented with sulfur amino acids have increased cysteine dioxygenase activity and increased taurine production in hepatocytes. J Nutr 125:933-940.
6. Blondel O, Bailbe D, Portha B (1990) Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phlorizin treatment. Metabolism 39:787-793.
7. Chang KJ (2000) Effect of taurine and b -alanine on morphological changes of pancreas in streptozotocin- induced rats. Adv Expt Med Biol 483:571-577.
8. Chiang LM, Jong YJ, Huang SC, Tsai JL, Pang CY, Lee HC, Wei YH (1995) Heteroplasmic mitochondrial DNA mutation in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. J Formos Med Assoc 94:42-47.
9. Davies WE, Harding NJ, Kay IS, Hopkins PC (1994) The role of taurine in mammalian hearing. Adv Expt Biol Med 359:393-398.
10. Gaull GE (1986) Taurine as a conditionally essential nutrient in man. J Am Coll Nutr 5:121-125.
11. Geggel HS, Ament ME, Heckenlively JR, Martin DA, Koppel JD (1985) Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N Engl J Med 312:142-146.
12. Golubnitschaja O, Moenkemann H, Kim K, Mozaffari MS (2003) DNA damage and expression of checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in taurine-deficient cardiomyocytes. Biochem Pharmacol 66:511-517.
13. Han X, Chesney RW (2012) The role of taurine in renal disorders. Amino Acids 43:2249-2263.
14. Hansen SH (2001) The role of taurine in diabetes and the development of diabetic complications. Diabetes/Metabol Res Rev 17:330-346.
15. Harris NG, Plant HD, Inglis BA, Briggs RW, Jones HC (1997) Neurochemical changes in the cerebral cortex of treated and untreated hydrocephalic rat pups quantified with in vitro 1H-NMR spectroscopy. J Neurochem 68:305-312.
16. Hayes KC, Carey RE, Schmidt SY (1975) Retinal degeneration associated with taurine deficiency in the cat. Science 188:949-951.
17. Hayes KC, Stephan ZF, Sturman JA (1980) Growth depression in taurine-depleted infant monkeys. J Nutr 110:2058-2064.
18. Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U, Haussinger D (2002) Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 16:231-233.
19. Hilton G (1995) MELAS: a mitochondrial encephalomyopathy syndrome. J Neurosci Nurs 27:278-282.
20. Hirano M, Konishi K, Arata N, Iyori M, Saruta T, Kuramochi S, Akizuki M (2002) Renal complications in a patient with A-to-G mutation of mitochondrial DNA at the 3243 position of leucine tRNA. Int Med 41:113-118.
21. Hirano M, Pavlakis SG (1994) Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS): current concepts. J Child Neurol 9:4-13.
22. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101-163.
23. Iizuka T, Sakai F (2005) Pathogenesis of stroke-like episodes in MELAS: Analysis of neurovascular cellular mechanisms. Current Neurovasc Res 2:29-45.
24. Imaki H, Moretz R, Wisniewski H, Neuringer M, Sturman J (1987) Retinal degeneration in 3-month-old rhesus monkey infants fed a taurine-free human infant formula. J Neurosci Res 18:602-614.
25. Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927-937.
26. Jacobsen JG, Smith LH Jr (1968) Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48:424-511.
27. Jong CJ, Azuma J, Schaffer S (2012) Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids 42:2223-2232.
28. Kirino Y, Yasukawa T, Ohta S, Akira S, Ishihara K, Watanabe K, Suzuki T (2004) Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc Natl Acad Sci 101:15070-15075.
29. Lake N, de Roode M, Nattel S (1987) Effects of taurine depletion on rat cardiac electrophysiology: in vivo and in vitro studies. Life Sci 40:997-1005.
30. Lake N, Malik N, De Marte L (1988) Taurine depletion leads to loss of rat optic nerve axons. Vision Res 28:1071-1076.
31. Latkany P, Ciulla TA, Cucchillo P, Malkoff MD (1999) Mitochondrial maculopathy: Geographic atrophy of the macula in the MELAS associated A to G 3243 mitochondrial DNA point mutation. Am J Ophthalmol 128:112-114.
32. Maassen JA, Hat LM, van Essen E, Heine RJ, Nijpels G, Tafrechi RSJ, Raap AK, Janssen GMC, Lemkes HHPJ (2004) Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53(Suppl 1):S103-S109.
33. Maassen JA, Hart LM, Janssen GMC, Reiling E, Romijn JA, Lemkes HH (2006) Mitochondrial diabetes and its lessons for common type 2 diabetes. Biochem Soc Trans 34:819-823.
34. Mozaffari MS, Patel C, Abdelsayad R, Schaffer SW (2006) Accelerated NaCl-induced hypertension in taurine-deficient rat: role of renal function. Renal Int 70:329-337.
35. Mozaffari MS, Tan BH, Lucia MA, Schaffer SW (1986) Effect of drug-induced taurine depletion on cardiac contractility and metabolism. Biochem Pharmacol 35:985-989.
36. Novotny MJ, Hogan PM, Flannigan G (1994) Echocardiographic evidence for myocardial failure induced by taurine deficiency in domestic cats. Can J Vet Res 58:6-12.
37. Novotny MJ, Hogan PM, Paley DM, Adams HR (1991) Systolic and diastolic dysfunction of the left ventricle induced by taurine deficiency in cats. Am J Physiol 261:H121-H127.
38. Oermann E, Warskulat U, Heller-Stilb B, Haussinger D, Zilles K (2005) Taurine-transporter gene knockout-induced changes in GABA A, kainite and AMPA but not NMDA receptor binding in mouse brain. Anat Embryol 210:363-372.
39. Pasantes-Morales H, Arzate ME, Quesada O, Huxtable RJ (1987) Higher susceptibility of taurinedeficient rats to seizures induced by 4-aminopyridine. Neuropharmacology 26:1721-1725.
40. Pion PD, Kittleson MD, Thomas WP, Skiles ML, Rogers QR (1992) Clinical findings in cats with dilated cardiomyopathy and relationship offindings to taurine deficiency. J Am Vet Med Assoc 201:267-274.
41. Pion PD, Kittleson MD, Rogers QR, Morris JG (1987) Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764-748.
42. Roysommuti S, Suwanich A, Lerdweeraphon W, Thaeomor A, Jirakulsomchok D, Wyss JM (2009) Sex dependent effects of perinatal taurine exposure on the arterial pressure control in adult offspring. Adv Exp Med Biol 643:135-144.